Patrick Finley, PharmD
Professor
Clinical Pharmacy
School of Pharmacy

He is a nationally recognized expert in the pharmacological management of mood disorders, with an emphasis on the treatment of mental illness in perinatal populations. He has additional expertise in the field of pharmacokinetics, particularly as it applies to potential drug interactions and associated toxicities with psychotropic medications. Dr. Finley also completed a certificate program in Outcomes Research and Epidemiology through the UCSF School of Medicine and has applied this training to conduct clinical and translational research using large databases (eg - California State Medicaid). He is a committed advocate to the cause of optimizing the medical treatment of the mentally ill and is actively involved in professional organizations and the community at large to promote safe and efficacious medication use.

• Enhancing our understanding of perinatal depression.
  CNS spectrums 2015 Finley PR, Brizendine L
• Detection and treatment rates for perinatal depression in a state Medicaid population.
  CNS spectrums 2014 Geier ML, Hills N, Gonzales M, Tum K, Finley PR
• A pilot study evaluating genetic and environmental factors for postpartum depression.
  Innovations in clinical neuroscience 2013 El-Ibiary SY, Hamilton SP, Abel R, Erdman CA, Robertson PA, Finley PR
• Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression.
  Journal of the American Pharmacists Association : JAPhA 2011 Finley PR, Bluml BM, Bunting BA, Kiser SN
• Pharmacologic treatment for postpartum depression: a systematic review.
  Pharmacotherapy 2010 Ng RC, Hirata CK, Yeung W, Haller E, Finley PR
• Heart of Pharmacy: a course exploring the psychosocial issues of patient care.
  American journal of pharmaceutical education 2009 Vogt EM, Finley PR
• Clarification of study and citation.
  Archives of internal medicine 2007 Finley PR, Bero L
• Tamoxifen treatment and new-onset depression in breast cancer patients.
  Psychosomatics 2007 Lee KC, Ray GT, Hunkeler EM, Finley PR
• Antidepressants, suicide, and the FDA: a loose association.
  The Annals of pharmacotherapy 2004 Finley PR
• Antiretroviral adherence in persons with HIV/AIDS and severe mental illness.
  The Journal of nervous and mental disease 2004 Kemppainen JK, Levine R, Buffum M, Holzemer W, Finley P, Jensen P
• Evaluating the impact of pharmacists in mental health: a systematic review.
  Pharmacotherapy 2003 Finley PR, Crismon ML, Rush AJ
• Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial.
  Pharmacotherapy 2003 Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Lee JY, Bero LA
• Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings.
  Expert opinion on drug safety 2003 Lee KC, Finley PR, Alldredge BK
• Impact of a collaborative pharmacy practice model on the treatment of depression in primary care.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002 Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA
• Atypical antipsychotics and tardive dyskinesia.
  Journal of managed care pharmacy : JMCP 2002 Finley PR
• Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.
  Clinical therapeutics 2002 Del Paggio D, Finley PR, Cavano JM
• Risperidone: clinical outcome predictors and cost-effectiveness in a naturalistic setting.
  Psychopharmacology bulletin 1998 Finley PR, Sommer BR, Corbitt JL, Brunson GH, Lum BL
• Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction.
  Journal of clinical psychopharmacology 1996 Finley PR, O'Brien JG, Coleman RW
• Clinical relevance of drug interactions with lithium.
  Clinical pharmacokinetics 1995 Finley PR, Warner MD, Peabody CA
• Measurement of prostaglandin E2 in rectal mucosa in human subjects: a method study.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995 Finley PR, Bogert CL, Alberts DS, Einspahr J, Earnest DL, Blackwell G, Girodias K
• Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
  The Annals of pharmacotherapy 1994 Finley PR
• Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994 Salmon SE, Crowley JJ, Grogan TM, Finley P, Pugh RP, Barlogie B
• Potential impact of valproic acid therapy on clozapine disposition.
  Biological psychiatry 1994 Finley P, Warner D
• An in vivo model of human multidrug-resistant multiple myeloma in SCID mice.
  The American journal of pathology 1993 Bellamy WT, Odeleye A, Finley P, Huizenga B, Dalton WS, Weinstein RS, Hersh EM, Grogan TM
• Chyle leakage after blunt trauma.
  Lymphology 1992 Skála J, Witte C, Bruna J, Case T, Finley P
• Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation.
  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1991 Butman SM, Wild JC, Nolan PE, Fagan TC, Finley PR, Hicks MJ, Mackie MJ, Copeland JG
• Characterization of ascites present at cesarean section.
  American journal of perinatology 1991 Calvin S, Silva M, Weinstein L, Finley P, Witte M
• Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis.
  Pediatric pulmonology 1991 Brown MA, Morgan WJ, Finley PR, Scuderi P
• Regulation of tumor necrosis factor secretion in leukocytes from alpha-1-antitrypsin deficient humans.
  Immunological investigations 1990 Scuderi P, Finley PR, Shon BY, Udall JN, Roe DJ, Chong AS
• Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990 Salmon SE, Tesh D, Crowley J, Saeed S, Finley P, Milder MS, Hutchins LF, Coltman CA, Bonnet JD, Cheson B
• Effect of interleukin-2 on microvascular liquid and protein transport in the rat small intestine.
  Lymphology 1990 Stuntz ME, Witte MH, Witte CL, Way DL, Champsi JH, Finley PR
• Comparison of ultrasonically applied vs. intra-articular injected hydrocortisone levels in canine knees.
  Orthopaedic review 1990 Muir WS, Magee FP, Longo JA, Karpman RR, Finley PR
• Plasma levels of fibronectin and prostacyclin metabolite in peripartum preeclamptic women.
  American journal of perinatology 1990 Calvin S, Weinstein L, Witte MH, Finley PR
• Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.
  Blood 1990 Durie BG, Stock-Novack D, Salmon SE, Finley P, Beckord J, Crowley J, Coltman CA
• Immunochemical assays for IgG, IgA, IgM and transferrin compared.
  Clinical biochemistry 1989 Christenson RH, Finley PR, Silverman LM
• Alpha-globulins suppress human leukocyte tumor necrosis factor secretion.
  European journal of immunology 1989 Scuderi P, Dorr RT, Liddil JD, Finley PR, Meltzer P, Raitano AB, Rybski J
• Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam.
  DICP : the annals of pharmacotherapy 1989 Finley PR, Nolan PE
• Gonadotropin deficiency in Tourette's syndrome: a preliminary communication.
  The International journal of neuroscience 1988 Sandyk R, Bamford CR, Binkiewicz A, Finley PR
• Raised serum levels of tumour necrosis factor in parasitic infections.
  Lancet (London, England) 1986 Scuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG, Petersen E, Slymen DJ, Salmon SE
• Amitriptyline plasma protein binding: effect of plasma pH and relevance to clinical overdose.
  The American journal of emergency medicine 1986 Levitt MA, Sullivan JB, Owens SM, Burnham L, Finley PR
• Office and clinic laboratories. Maintaining quality control.
  American journal of diseases of children (1960) 1986 Finley PR, Ryan KJ
• Methotrexate: bioavailability and pharmacokinetics.
  Cancer treatment reports 1985 Campbell MA, Perrier DG, Dorr RT, Alberts DS, Finley PR
• Liquid-chromatographic determination of vancomycin evaluated and improved.
  Clinical chemistry 1984 Bever FN, Finley PR, Fletcher C, Williams J
• Re: Myocardial contusion following nonfatal blunt chest trauma.
  The Journal of trauma 1984 Lindsey D, Finley PR
• AIDS in 1968.
  JAMA 1984 Witte MH, Witte CL, Minnich LL, Finley PR, Drake WL
• Increased activities of MB and BB isozymes of creatine kinase in denervated neonatal and adult rat muscle.
  Experimental neurology 1984 Sadeh M, Stern LZ, Czyzewski K, Finley PR, Russell DH
• Alterations in creatine kinase, ornithine decarboxylase, and transglutaminase during muscle regeneration.
  Life sciences 1984 Sadeh M, Stern LZ, Czyzewski K, Finley PR, Russell DH
• Influence of ascites on tobramycin pharmacokinetics.
  Journal of clinical pharmacology 1984 Sampliner R, Perrier D, Powell R, Finley P
• Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984 Garewal H, Durie BG, Kyle RA, Finley P, Bower B, Serokman R
• Phagocytic, lambda light chain, plasma cell myeloma.
  American journal of clinical pathology 1983 Wirt DP, Grogan TM, Payne CM, Kummet TD, Durie BG, Finley PR, Rollins D
• Effect of alcohols and selected solvents on serum osmolality measurements.
  Journal of toxicology. Clinical toxicology 1983 Lund ME, Banner W, Finley PR, Burnham L, Dye JA
• Valproic acid pharmacokinetics in the mouse following controlled-release of pharmacologic and toxic doses via novel implantable and refillable drug reservoirs.
  Biopharmaceutics & drug disposition 1983 Nau H, Finley P, Williams J, Brendel K
• Lidocaine elimination: effects of metoprolol and of propranolol.
  Clinical pharmacology and therapeutics 1983 Conrad KA, Byers JM, Finley PR, Burnham L
• Assay of cerebrospinal fluid protein: a rate biuret method evaluated.
  Clinical chemistry 1983 Finley PR, Williams RJ
• The in utero management of urinary outflow tract obstruction.
  Journal of clinical ultrasound : JCU 1982 Weinstein L, Anderson CF, Finley PR, Lichti DA
• RBC zinc protoporphyrin to screen blood donors for iron deficiency anemia.
  JAMA 1982 Schifman RB, Rivers SL, Finley PR, Thies C
• Kinetics of the digoxin-aspirin combination.
  Clinical pharmacology and therapeutics 1982 Fenster PE, Comess KA, Hanson CD, Finley PR
• Rheumatoid factor activity by rate nephelometry correlated with clinical activity in rheumatoid arthritis.
  American journal of clinical pathology 1982 Hicks MJ, Heick M, Finley P, Gall EP, Minnich L, Williams RJ
• Cimetidine decreases theophylline clearance.
  Annals of internal medicine 1981 Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finley PR
• Rate-nephelometric inhibition immunoassay of phenytoin and phenobarbital.
  Clinical chemistry 1981 Finley PR, Dye JA, Williams RJ, Lichti DA
• Serum CPK isoenzyme BB as an indicator of brain tissue damage following head injury.
  The Journal of trauma 1981 Karpman RR, Weinstein PR, Finley PR, Karst-Sabin B
• A cellulose acetate electrophoretic procedure evaluated for quantitation of high-density lipoprotein cholesterol.
  Clinical chemistry 1981 Schifman RB, Brumbaugh PF, Grover D, Finley PR, Harrow EJ
• Measurement of near-normal concentrations of erythrocyte protoporphyrin with the hematofluorometer: influence of plasma on "front-surface illumination" assay.
  Clinical chemistry 1981 Schifman RB, Finley PR
• Evaluation of a new homogeneous enzyme inhibitor immunoassay of serum thyroxine with use of a bichromatic analyzer.
  Clinical chemistry 1980 Finley PR, Williams RJ, Lichti DA
• Adaptation of the enzyme-multiplied immunoassay for methotrexate to the centrifugal analyzer.
  Clinical chemistry 1980 Finley PR, Williams RJ, Griffith F, Lichti DA
• Rate nephelometric measurement of rheumatoid factor in serum.
  Clinical chemistry 1979 Finley PR, Hicks MJ, Williams RJ, Hinlicky J, Lichti DA
• Stability of solutions of human granulocyte lactate dehydrogenase stored at different temperatures.
  Transfusion 1979 Glasser L, Finley PR
• Meaning of elevated CK-MB.
  American heart journal 1979 Lindsey D, Navin T, Finley P
• Changes in immunoglobulin control sera.
  Clinical chemistry 1979 Finley PR
• Immunochemical determination of human immunoglobulins: use of kinetic turbidimetry and a 36-place centrifugal analyzer.
  Clinical chemistry 1979 Finley PR, Williams RJ, Lichti DA, Griffith F, Thies AC
• Evaluation of a new multichannel analyzer, "Astra-8".
  Clinical chemistry 1978 Finley PR, Williams RJ, Lichti DA, Thies AC
• Transient elevation of serum activity of MB isoenzyme of creatine phosphokinase in drivers involved in automobile accidents.
  Chest 1978 Lindsey D, Navin TR, Finley PR
• A modified ion-selective electrode method for measurement of chloride in sweat.
  American journal of clinical pathology 1978 Finley PR, Dye JA, Lichti DA, Byers JM, Williams RJ
• Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement.
  Clinical chemistry 1978 Finley PR, Schifman RB, Williams RJ, Lichti DA
• Evaluation of homogeneous enzyme immunoassay of serum thyroxine with use of bichromatic analysis.
  Clinical chemistry 1978 Finley PR, Williams RJ
• Methotrexate assay by enzymatic inhibition, with use of centrifugal analyzer.
  Clinical chemistry 1977 Finley PR, Williams RJ
• Assay of phenobarbital: adaption of "EMIT" to the centrifugal analyzer.
  Clinical chemistry 1977 Finley PR, Willaims RJ, Lichti DF, Byers JM
• Immunochemical determination of human immunoglobulins with a centrifugal analyzer.
  Clinical chemistry 1976 Finley PR, Williams RJ, Byers JM
• Assay of phenytoin: adaptation of "EMIT" to the centrifugal analyzer.
  Clinical chemistry 1976 Finley PR, Williams RJ, Byers JM
• Hageman factor.
  Annals of clinical laboratory science 1972 Finley PR
• Hypergammaglobulinemia.
  Minnesota medicine 1970 Finley PR
• Changes in antithrombin 3 and plasminogen induced by oral contraceptives.
  American journal of clinical pathology 1970 Peterson RA, Krull PE, Finley P, Ettinger MG
• Electronic data processing in a private hospital laboratory.
  American journal of clinical pathology 1967 Finley PR, Anderson F, Neese R
• METHEMOGLOBINEMIA IN A HOSPITAL NURSERY: A SEARCH FOR CAUSATIVE FACTORS.
  JAMA 1963 FISCH RO, BERGLUND EB, BRIDGE AG, FINLEY PR, QUIE PG, RAILE R
• Distribution of radioactivity in man after the oral ingestion of small test doses of radiolabeled cyanocobalamin.
  The Journal of laboratory and clinical medicine 1960 DOSCHERHOLMEN A, FINLEY PR, HAGEN PS